Filing Details
- Accession Number:
- 0000950103-21-002457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 20:18:54
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-02-17 20:18:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1828182 | Signify Health Inc. | SGFY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1672957 | Steve Senneff | C/O Signify Health, Inc. 800 Connecticut Avenue Norwalk CT 06854 | Pres., Chief Fin. & Admin Off. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-02-12 | 98,214 | $0.00 | 98,214 | No | 4 | A | Direct | |
Class B Common Stock | Acquisiton | 2021-02-12 | 506,975 | $0.01 | 506,975 | No | 4 | A | Direct | |
Class A Common Stock | Acquisiton | 2021-02-16 | 13,900 | $24.00 | 112,114 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Options (Right to Buy) | Acquisiton | 2021-02-12 | 883,932 | $0.00 | 883,932 | $8.46 |
Class A Common Stock | LLC Units in Cure Aggregator, LLC | Acquisiton | 2021-02-12 | 506,975 | $0.00 | 506,975 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
883,932 | 2029-06-10 | No | 4 | A | Direct | |
506,975 | No | 4 | A | Direct |
Footnotes
- These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in New Remedy Corp.
- These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC.
- These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
- The stock options service-vest in equal installments on each of March 14, 2021, 2022 and 2023 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified multiple of invested capital return thresholds.
- The LLC Units service-vest 25% on each of the first four anniversaries of February 18, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.